Product image of Levetiracetam Brillpharma (Levetiracetam) supplied by GNH India

Levetiracetam Brillpharma

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Brillpharma (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Brillpharma, is an anticonvulsant presented as a tablet in various strengths for oral use. It treats partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients diagnosed with epilepsy.

GNH India supplies Levetiracetam Brillpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Brillpharma Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levetiracetam is an antiepileptic drug indicated for several seizure types:

  • Partial‑onset seizures: reduces frequency of focal seizures in adults and children.
  • Generalized tonic‑clonic seizures: helps control convulsive episodes across age groups.
  • Myoclonic seizures: diminishes rapid, involuntary muscle jerks associated with juvenile myoclonic epilepsy.

How It Works

  • Levetiracetam binds to the synaptic vesicle protein SV2A, modulating neurotransmitter release and stabilizing neuronal firing. This interaction decreases abnormal neuronal excitability, thereby lowering the likelihood of seizure generation and propagation within the central nervous system.

Side Effects

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects

  • Drowsiness: feeling unusually sleepy or fatigued.
  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Headache: mild to moderate cranial pain.
  • Irritability: increased mood swings or agitation.
  • Nausea: upset stomach or urge to vomit.
  • Nasal congestion: blocked or runny nose.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, swelling, or difficulty breathing.
  • Mood changes: depression, suicidal thoughts, or aggressive behavior.
  • Blood disorders: low white blood cells or platelets.
  • Liver dysfunction: jaundice or elevated liver enzymes.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Precautions & Warnings

Before initiating therapy, consider the following safety measures:

  • Renal function: assess kidney performance and adjust dose if impairment is present.
  • Hepatic status: monitor liver enzymes in patients with liver disease.
  • Psychiatric history: watch for mood alterations, especially in those with prior depression or anxiety.
  • Concomitant CNS depressants: avoid excessive sedation when combined with other central nervous system depressants.
  • Pregnancy and lactation: discuss potential risks with a healthcare professional before use.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Avoid Interactions

Levetiracetam can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid)

  • Carbamazepine: may reduce levetiracetam plasma levels, decreasing seizure control.
  • Phenobarbital: can lower levetiracetam concentrations, risking breakthrough seizures.

Moderate Interactions (Monitor Closely)

  • Oral contraceptives: levetiracetam may diminish hormonal contraceptive effectiveness.
  • Sedative agents (e.g., benzodiazepines): additive CNS depression may occur.
  • Antidepressants: monitor for increased irritability or mood changes.
  • Immunosuppressants: observe for altered drug levels, especially in transplant patients.

Frequently Asked Questions

Levetiracetam Brillpharma is prescribed to manage partial‑onset seizures, generalized tonic‑clonic seizures, and myoclonic seizures in patients with epilepsy. It helps reduce the frequency and severity of these seizure types when used as part of a comprehensive treatment plan.

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. By stabilizing neuronal firing and decreasing abnormal excitability, the drug lowers the likelihood of seizure initiation and spread throughout the brain.

The specific dose of Levetiracetam Brillpharma is determined by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Dosage adjustments are individualized and should follow the prescriber’s instructions.

Safety data for levetiracetam in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits and risks before prescribing to pregnant or nursing individuals, and discuss alternative options when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancers such as phenobarbital. It is generally well‑tolerated, has fewer drug‑enzyme interactions, and can be used as monotherapy or adjunct therapy depending on clinical needs.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure the packaging remains tightly closed to maintain product stability.

Levetiracetam Brillpharma is taken orally, usually with or without food. Tablets should be swallowed whole with water. The exact administration schedule—once daily, twice daily, or more—depends on the prescriber’s dosing regimen.

Serious risks include severe allergic reactions (e.g., rash, swelling, breathing difficulty), mood disturbances such as depression or suicidal thoughts, and rare blood disorders. Patients should seek immediate medical attention if any of these symptoms develop.

Levetiracetam is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting medications without proper monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT